China cancer patient who inspired hit film hopes to stop treatment after 35,000 pills over 2 decades

Read the original at South China Morning Post ↗
Cite

Yan, A. (2026, October 23). China cancer patient who inspired hit film hopes to stop treatment after 35,000 pills over 2 decades. South China Morning Post. https://www.scmp.com/news/people-culture/china-personalities/article/3371839/china-cancer-patient-who-inspired-hit-film-hopes-stop-treatment-after-35000-pills-over-2-decades

Dated from the outlet's own feed. Check the original for its byline.

South China Morning Post · collected 2026-10-23 · by Alice Yan

Quick Summary

Lu Yong, a Chinese cancer patient diagnosed with chronic myeloid leukemia (CML) in 2002, hopes to stop taking medication after consuming over 35,000 pills over two decades. Lu's story inspired the hit film "Dying to Survive," which led to healthcare reforms for cancer patients in China. Initially using Gleevec from Novartis, Lu faced prosecution for helping fellow patients access affordable generic drugs from India before health authorities implemented reforms.
Written locally by qwen2.5:14b on 2026-10-23, using this article's own text rather than the other coverage of the same event (that is the story summary below).

AI analysis runs on qwen2.5:14b, locally

Story summary

Lu Yong, a Chinese cancer patient who inspired the 2018 hit film "Dying to Survive," has begun reducing his medication and hopes to stop taking it completely within three months after taking over 35,000 pills over two decades for his chronic myeloid leukaemia (CML). Lu's story, which highlighted the struggle of patients seeking affordable life-saving generic drugs from India, led Chinese health authorities to fast-track critical healthcare reforms. Initially diagnosed with CML in 2002, Lu took Gleevec, a patented drug made by Novartis, but later helped other patients access cheaper generics, for which he was prosecuted by Chinese authorities for selling "fake drugs." Before his diagnosis, Lu worked as a textiles trader in Jiangsu province.

Written for “Cancer Patient's Treatment Journey Ends Hope” on 2026-10-23, grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
This article does not take a side on a contested political question, so it has no leaning score. That is an answer rather than a gap: a match report or a rescue can be warmly or critically written without being left or right, and scoring it anyway is how approval of a subject gets recorded as a political position.
No political leaning scored for article 100791 · logged 2026-10-23

Story

📰 Cancer Patient's Treatment Journey Ends Hope
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
4
sentences that state something as happening or true
Uncertain
0%
0 of 4 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
South China Morning Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-23 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

South China Morning Post · 2901 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)
2026-10-16
Nobel Peace Prize: the message behind Navi Pillay’s win
2026-10-16
Indonesian governor’s Singapore trip adds fury to forest fire, haze crisis
2026-10-04
Flight to Okinawa diverts back to Hong Kong after suspected landing gear fault
2026-10-04
Tennessee prisons chief resigning after botched execution of Christa Pike
2026-09-29
Indonesian prison chief suspended over secret VIP compound for inmates
2026-09-28
Trump ‘arms offer’ to China jolts Washington into moves to contain the fallout

Who wrote this

Alice Yan
23 article(s) here · 0 carrying a prediction
🔮 China AI researcher rises to Xiaomi’s top level in 10 months, talks work-life balance I am like a snail who does not pursue the fastest move, but my every step is clearly visible, Luo says of her character Beijing-based smartphone and electric vehicle giant Xiaomi announced in mid-October that it would promote 31-year-old Luo Fuli to its highest-level position, once again putting the “AI prodigy” at the centre of heated discussion. The move came 10 months after Luo joined the company as head of its large language model (LLM) unit.
2026-10-21 · assertive framing · China AI researcher rises to Xiaomi’s top level in 10 months, talks work-life balance
🔮 Under the city’s Restraining Dog Raising Rules, owners of small ornamental dogs in designated “key restraining” areas may walk their pets only between 7pm and 7am.
2026-10-16 · mixed framing · China tech city dog-walking limits criticised; some question ‘how dogs can get some sunshine’
🔮 Some of these may surprise people from other cultures because they sound humble or even unflattering.
2026-10-15 · mixed framing · Ancient Chinese families gave babies humble nicknames – ‘Dog’, ‘Pig’ – to ward off bad luck
🔮 However, no institution was willing to accept her as a student due to her age, prompting her to take matters into her own hands.
2026-10-05 · mixed framing · Chinese ‘Coffee Grandma’ learns brewing to save son’s cafe, inspires female independence
🔮 China ‘living Buddha’ honoured for US$9 million donation after saving every cent for charity Wang is leaving no inheritance to his children, having informed them that his wealth will continue to be donated even after his passing A 98-year-old man in eastern China has garnered widespread praise for his remarkable philanthropy, which includes donations totalling 60 million yuan (US$9 million), while leading an exceptionally frugal life himself. Wang Chunwen, a resident of Ninghai county in Zhejiang province, has been honoured with the China Charity Award by the Ministry of Civil Affairs, the highest accolade in the country to recognise significant contributions to charitable efforts.
2026-09-10 · assertive framing · China ‘living Buddha’ honoured for US$9 million donation after saving every cent for charity
Also by Alice Yan
China AI researcher rises to Xiaomi’s top level in 10 months, talks work-life balance
2026-10-21 · South China Morning Post
China celebrities speak out on mental health diagnoses to seek authentic connections with fans
2026-10-20 · South China Morning Post
No fuss, just dinner: China couple trade wedding extravagance for US$11,000 feast, cash gifts
2026-10-19 · South China Morning Post
Strangers and railway staff help Chinese couple bring quintuplets home by train
2026-10-17 · South China Morning Post
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 23 articles by Alice Yan →

Topics

China Chinese India Jiangsu province Novartis

Subjects

China GPE · 3× Chinese NORP · 2× India GPE · 1× Jiangsu province GPE · 1× Lu Yong PERSON · 1× Novartis ORG · 1×

Narrative

China cancer patient who inspired hit film hopes to stop treatment after 35,000 pills over 2 decades Driven by the cinematic impact of ‘Dying to Survive’, Chinese health authorities fast-tracked critical healthcare reforms for cancer patients Lu Yong, who has a slow-growing blood and bone marrow cancer and inspired the 2018 blockbuster Dying to Survive, has begun reducing his medication and hopes to stop taking it completely within three months.
framing: assertive · carried by 1 article(s) · first seen 2026-10-23
2026-10-23 · South China Morning Post
China cancer patient who inspired hit film hopes to stop treatment after 35,000 pills over 2 decades · assertive framing

Claims (4 extracted, 0 hedged)

China cancer patient who inspired hit film hopes to stop treatment after 35,000 pills over 2 decades Driven by the cinematic impact of ‘Dying to Survive’, Chinese health authorities fast-tracked critical healthcare reforms for cancer patients Lu Yong, who has a slow-growing blood and bone marrow cancer and inspired the 2018 blockbuster Dying to Survive, has begun reducing his medication and hopes to stop taking it completely within three months. asserted
who → inspire → months
The acclaimed film is based on Lu’s experience. asserted
film → base → experience
He has chronic myeloid leukaemia (CML) and helped patients across China obtain affordable, life-saving generic drugs from India, but was prosecuted by Chinese authorities for selling “fake drugs”. asserted
patients → have → drugs
Diagnosed with CML in 2002, he took Gleevec, a patented drug made by Novartis, for the first few years. asserted
he → diagnose → years
💬Give feedback
🕘History 🎫Support
Terms · Privacy · beta v2.0.0
Articles to 23 Oct 2026